220 related articles for article (PubMed ID: 17380268)
41. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.
Maher S; Heade J; McCartney F; Waters S; Bleiel SB; Brayden DJ
Int J Pharm; 2018 Mar; 539(1-2):11-22. PubMed ID: 29341916
[TBL] [Abstract][Full Text] [Related]
42. Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials.
Ude VC; Brown DM; Stone V; Johnston HJ
J Nanobiotechnology; 2019 May; 17(1):70. PubMed ID: 31113462
[TBL] [Abstract][Full Text] [Related]
43. Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol.
Maher S; McClean S
Biochem Pharmacol; 2008 Mar; 75(5):1104-14. PubMed ID: 18068148
[TBL] [Abstract][Full Text] [Related]
44. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
45. Cl- secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6).
Kreusel KM; Fromm M; Schulzke JD; Hegel U
Am J Physiol; 1991 Oct; 261(4 Pt 1):C574-82. PubMed ID: 1656765
[TBL] [Abstract][Full Text] [Related]
46. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
47. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Pharm Pharmacol; 2006 May; 58(5):591-8. PubMed ID: 16640827
[TBL] [Abstract][Full Text] [Related]
48. Permeation-enhancing effect of aloe-emodin anthrone on water-soluble and poorly permeable compounds in rat colonic mucosa.
Kai M; Hayashi K; Kaida I; Aki H; Yamamoto M
Biol Pharm Bull; 2002 Dec; 25(12):1608-13. PubMed ID: 12499649
[TBL] [Abstract][Full Text] [Related]
49. In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa.
Lecluyse EL; Sutton SC; Fix JA
J Pharmacol Exp Ther; 1993 May; 265(2):955-62. PubMed ID: 8496836
[TBL] [Abstract][Full Text] [Related]
50. Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.
Nishimura N; Uemura T; Iwamoto K; Naora K
J Pharm Pharmacol; 2010 May; 62(5):651-7. PubMed ID: 20609069
[TBL] [Abstract][Full Text] [Related]
51. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells.
Behrens I; Stenberg P; Artursson P; Kissel T
Pharm Res; 2001 Aug; 18(8):1138-45. PubMed ID: 11587485
[TBL] [Abstract][Full Text] [Related]
52. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
53. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
Gagnon M; Zihler Berner A; Chervet N; Chassard C; Lacroix C
J Microbiol Methods; 2013 Sep; 94(3):274-9. PubMed ID: 23835135
[TBL] [Abstract][Full Text] [Related]
55. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.
Boegh M; García-Díaz M; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):136-43. PubMed ID: 25622791
[TBL] [Abstract][Full Text] [Related]
56. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
Patel N; Forbes B; Eskola S; Murray J
Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
[TBL] [Abstract][Full Text] [Related]
57. Heat-shock protein 72 protects against oxidant-induced injury of barrier function of human colonic epithelial Caco2/bbe cells.
Musch MW; Sugi K; Straus D; Chang EB
Gastroenterology; 1999 Jul; 117(1):115-22. PubMed ID: 10381917
[TBL] [Abstract][Full Text] [Related]
58. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
59. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.
Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162
[TBL] [Abstract][Full Text] [Related]
60. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
